Revolution Medicines
RVMD
RVMD
255 hedge funds and large institutions have $7.74B invested in Revolution Medicines in 2024 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 92 increasing their positions, 64 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.09% more ownership
Funds ownership: 102.07% → 102.16% (+0.09%)
0% more funds holding in top 10
Funds holding in top 10: 18 → 18 (0)
64% less call options, than puts
Call options by funds: $13.2M | Put options by funds: $36.9M
Holders
255
Holding in Top 10
18
Calls
$13.2M
Puts
$36.9M
Top Buyers
| 1 | +$79.8M | |
| 2 | +$67.9M | |
| 3 | +$65.2M | |
| 4 |
JP Morgan Chase
New York
|
+$44.5M |
| 5 |
Goldman Sachs
New York
|
+$39.5M |
Top Sellers
| 1 | -$109M | |
| 2 | -$98.4M | |
| 3 | -$45.8M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$39.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$31M |